IP Library › Assignment 056969/0864
Patent Assignment
Reel/Frame 056969/0864

Assignment of Assignor's Interest

Recorded: 2021-05-27 Pages: 29
Assignor
ARAXES PHARMA LLC
Executed: 2020-10-08
Assignees
ARAXES PHARMA LLC
3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CALIFORNIA, 92121
JANSSEN BIOTECH, INC.
800/850 RIDGEVIEW DRIVE, HORSHAM, PENNSYLVANIA, 19044
Covered Properties (106)
Irreversible covalent inhibitors of Kras G12C
Application: 61/852,285 →
Irreversible Covalent Inhibitors of Kras G12C
Application: 61/889,328 →
Covalent Inhibitors of Kras G12C
Patent: 9,227,978 →
Application: 14/212,656 →
Publication: US 2014/0288045
Covalent Inhibitors of Kras G12C
Patent: 9,926,267 →
Application: 14/933,734 →
Publication: US 2016/0159738
Covalent Inhibitors of Kras G12C
Application: 15/891,304 →
Publication: US 2018/0162812
Covalent Inhibitors of Kras G12C
Application: 16/355,258 →
Publication: US 2019/0389796
Covalent inhibitors of KRAS G12C
Application: 61/852,123 →
Covalent Inhibitors of Kras G12C
Application: 61/889,480 →
Substituted Quinazolines as Inhibitors of Kras G12C
Patent: 9,840,516 →
Application: 14/511,425 →
Publication: US 2015/0239900
Substituted Quinolines as Inhibitors of Kras G12C
Application: 15/805,716 →
Publication: US 2018/0118757
Substituted Cinnolines as Inhibitors of Kras G12C
Application: 16/449,967 →
Publication: US 2020/0102321
Inhibitors of Kras G12C
Application: 61/889,460 →
Inhibitors of Kras G12C
Application: 62/034,619 →
Inhibitors of Kras G12C
Application: 62/052,366 →
Combination Therapies for Treatment of Cancer
Application: 14/858,766 →
Publication: US 2016/0166571
Combination Therapies for Treatment of Cancer
Application: 16/141,775 →
Publication: US 2019/0262342
Combination Therapies for Treatment of Cancer
Application: 62/052,332 →
Combination Therapies for Treatment of Cancer
Application: 62/195,633 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/055,188 →
Inhibitors of Kras G12C Mutant Proteins
Patent: 9,862,701 →
Application: 14/866,147 →
Publication: US 2016/0108019
Inhibitors of Kras G12C Mutant Proteins
Application: 15/817,075 →
Publication: US 2018/0141927
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,556 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,632 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,597 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,815 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,595 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,816 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/233,814 →
Inhibitors of Kras G12C Mutant Proteins
Application: 62/342,040 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/145,705 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/255,891 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 15/093,951 →
Publication: US 2016/0297774
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 16/281,905 →
Publication: US 2019/0284144
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/145,818 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/265,320 →
Fused-Tricyclic Inhibitors of Kras and Methods of Use Thereof
Application: 62/147,955 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/195,636 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/342,078 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 15/217,304 →
Publication: US 2017/0022184
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 15/916,075 →
Publication: US 2018/0194748
Methods for Preparation of Quinazoline Derivatives
Application: 62/265,303 →
Methods for Preparation of Quinazoline Derivatives
Patent: 9,988,357 →
Application: 15/373,832 →
Publication: US 2017/0190672
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Application: 15/353,402 →
Publication: US 2017/0197945
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Application: 16/514,675 →
Publication: US 2020/0181123
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Application: 62/255,879 →
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Application: 62/340,291 →
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Application: 62/406,247 →
Substituted Quinazoline Compounds and Methods of Use Thereof
Application: 62/265,316 →
Conjugates of Cereblon Binding Compounds and G12C Mutant Kras, Hras or Nras Protein Modulating Compounds and Methods of Use Thereof
Application: 62/361,810 →
Conjugates of Cereblon Binding Compounds and G12C Mutant Kras, Hras or Nras Protein Modulating Compounds and Methods of Use Thereof
Application: 15/649,568 →
Publication: US 2018/0015087
Substituted Isoquinolinone and Isoindolinone Compounds and Methods of Use Thereof
Application: 62/405,701 →
Inhibitors of Ras and Methods of Use Thereof
Application: 62/450,966 →
Inhibitors of Ras and Methods of Use Thereof
Application: 15/727,422 →
Publication: US 2018/0127396
Inhibitors of Kras G12C Mutant Proteins
Application: 62/401,345 →
Inhibitors of Kras G12C Mutant Proteins
Application: 15/721,021 →
Publication: US 2018/0155348
Inhibitors of Kras G12C Mutant Proteins
Application: 16/374,356 →
Publication: US 2020/0062761
Inhibitors of Ras Mutant Proteins and Methods of Use Thereof
Application: 62/450,914 →
Substituted Quinazoline and Quinazolinone Compounds and Methods of Use Thereof
Application: 62/450,939 →
Fused Bicyclic Benzoheteroaromatic Compounds and Methods of Use Thereof
Application: 62/450,925 →
Fused N-Heterocyclic Compounds and Methods of Use Thereof
Application: 62/450,953 →
Benzothiophene and Benzothiazole Compounds and Methods of Use Thereof
Application: 62/450,956 →
Fused Hetero-Hetero Bicyclic Compounds and Methods of Use Thereof
Application: 62/450,962 →
Covalent Inhibitors of Kras
Application: 62/511,163 →
Covalent Inhibitors of Kras
Application: 62/625,889 →
Covalent Inhibitors of Kras
Application: 15/989,015 →
Publication: US 2019/0062313
Covalent Inhibitors of Kras
Application: 16/915,942 →
Publication: US 2021/0024501
Compounds and Methods of Use Thereof
Application: 62/511,152 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/511,159 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/625,902 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 15/989,031 →
Publication: US 2019/0062314
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/713,371 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/713,298 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/773,084 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/750,009 →
Compounds and Methods of Use Thereof for Treatment of Cancer
Application: 62/773,104 →
Irreversible Covalent Inhibitors of Kras G12C
Covalent Inhibitors of Kras G12C
Inhibitors of Kras G12C
Combination Therapies for Treatment of Cancer
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Kras G12C Mutant Proteins
Substituted Quinazoline Compounds and Methods of Use Thereof
Fused-Tricyclic Inhibitors of Kras and Methods of Use Thereof
Substituted Quinazoline Compounds and Methods of Use Thereof
Methods for Preparation of Quinazoline Derivatives
2-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
Inhibitors of Ras and Methods of Use Thereof
Inhibitors of Kras G12C Mutant Proteins
Inhibitors of Ras Mutant Proteins and Methods of Use Thereof
Substituted Quinazoline and Quinazolinone Compounds and Methods of Use Thereof
Fused Bicyclic Benzoheteroaromatic Compounds and Methods of Use Thereof
Fused N-Heterocyclic Compounds and Methods of Use Thereof
Benzothiophene and Benzothiazole Compounds and Methods of Use Thereof
Fused Hetero-Hetero Bicyclic Compounds and Methods of Use Thereof
Covalent Inhibitors of Kras
Compounds and Methods of Use Thereof
Compounds and Methods of Use Thereof for Treatment of Cancer
Compounds and Methods of Use Thereof for Treatment of Cancer
Compounds and Methods of Use Thereof for Treatment of Cancer
Compounds and Methods of Use Thereof for Treatment of Cancer
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 18, 2013
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; FENG, JUN
To: ARAXES PHARMA LLC
Reel/Frame 030248/0015 →
Assignment of Assignor's Interest Apr 18, 2013
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; FENG, JUN
To: ARAXES PHARMA LLC
Reel/Frame 030247/0996 →
Assignment of Assignor's Interest Dec 4, 2013
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; FENG, JUN
To: ARAXES PHARMA LLC
Reel/Frame 031713/0333 →
Assignment of Assignor's Interest Dec 4, 2013
From: LI, LIANSHENG; FENG, JUN; WU, TAO; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 031713/0500 →
Assignment of Assignor's Interest Dec 4, 2013
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; FENG, JUN
To: ARAXES PHARMA LLC
Reel/Frame 031713/0071 →
Assignment of Assignor's Interest Sep 24, 2014
From: LI, LIANSHENG; FENG, JUN; WU, TAO; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 033808/0455 →
Assignment of Assignor's Interest Sep 26, 2014
From: LI, LIANSHENG; FENG, JUN; WU, TAO; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 033830/0356 →
Assignment of Assignor's Interest Nov 13, 2014
From: LI, LIANSHENG; FENG, JUN; REN, PINGDA; LIU, YI
To: ARAXES PHARMA LLC
Reel/Frame 034162/0625 →
Assignment of Assignor's Interest Feb 23, 2015
From: REN, PINGDA; LIU, YI; LI, LIANSHENG; FENG, JUN
To: ARAXES PHARMA LLC
Reel/Frame 035009/0071 →
Assignment of Assignor's Interest May 18, 2015
From: LI, LIANSHENG; FENG, JUN; WU, TAO; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 035660/0350 →
Assignment of Assignor's Interest Jun 16, 2015
From: JANES, MATTHEW ROBERT; PATRICELLI, MATTHEW PETER; LI, LIANSHENG; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 035923/0941 →
Assignment of Assignor's Interest Jun 16, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; LIU, YUAN
To: ARAXES PHARMA LLC
Reel/Frame 035923/0964 →
Assignment of Assignor's Interest Aug 27, 2015
From: JANES, MATTHEW ROBERT; PATRICELLI, MATTHEW PETER; LI, LIANSHENG; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 036443/0236 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037085/0759 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037005/0421 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037005/0444 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037005/0463 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; LIU, YUAN
To: ARAXES PHARMA LLC
Reel/Frame 037005/0616 →
Assignment of Assignor's Interest Nov 10, 2015
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037005/0487 →
Assignment of Assignor's Interest Jan 8, 2016
From: LI, LIANSHENG; FENG, JUN; REN, PINGDA; LIU, YI
To: ARAXES PHARMA LLC
Reel/Frame 037442/0871 →
Assignment of Assignor's Interest Jan 14, 2016
From: LI, LIANSHENG; FENG, JUN; REN, PINGDA; LIU, YI
To: ARAXES PHARMA LLC
Reel/Frame 037495/0750 →
Assignment of Assignor's Interest Mar 2, 2016
From: JANES, MATTHEW ROBERT; PATRICELLI, MATTHEW PETER; LI, LIANSHENG; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 037875/0569 →
Assignment of Assignor's Interest Aug 26, 2016
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 039850/0808 →
Assignment of Assignor's Interest Aug 26, 2016
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; LIU, YUAN
To: ARAXES PHARMA LLC
Reel/Frame 039556/0323 →
Assignment of Assignor's Interest Aug 26, 2016
From: LI, LIANSHENG; FENG, JUN; LONG, YUN OLIVER; LIU, YUAN
To: ARAXES PHARMA LLC
Reel/Frame 039849/0662 →